Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
CNTY-101 by Century Therapeutics for Primary Mediastinal B-Cell Lymphoma: Likelihood of Approval
CNTY-101 is under clinical development by Century Therapeutics and currently in Phase I for Primary Mediastinal B-Cell Lymphoma. According to...
CNTY-101 by Century Therapeutics for Mantle Cell Lymphoma: Likelihood of Approval
CNTY-101 is under clinical development by Century Therapeutics and currently in Phase I for Mantle Cell Lymphoma. According to GlobalData,...
CNTY-101 by Century Therapeutics for Marginal Zone B-cell Lymphoma: Likelihood of Approval
CNTY-101 is under clinical development by Century Therapeutics and currently in Phase I for Marginal Zone B-cell Lymphoma. According to...